MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study
- PMID:25211270
- DOI: 10.1097/SLA.0000000000000909
MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study
Abstract
Background: Retrospective single-center studies have shown that diffusion-weighted magnetic resonance imaging (DWI) is promising for identification of patients with rectal cancer with a complete tumor response after neoadjuvant chemoradiotherapy (CRT), using certain volumetric thresholds.
Objective: This study aims to validate the diagnostic value of these volume thresholds in a larger, independent, and bi-institutional patient cohort.
Methods: A total of 112 patients with locally advanced rectal cancer (2 centers) treated with a long course of CRT were enrolled. Patients underwent standard T2W-magnetic resonance imaging and DWI, both pre- and post-CRT. Two experienced readers independently determined pre-CRT and post-CRT tumor volumes (cm) on T2W-magnetic resonance image and diffusion-weighted magnetic resonance image by means of freehand tumor delineation. Tumor volume reduction rates (Δvolume) were calculated. Previously determined T2W and DWI threshold values for prevolume, postvolume, and Δvolume were tested to "prospectively" assess their respective diagnostic value in discriminating patients with a complete tumor response from patients with residual tumor.
Results: Twenty patients had a complete response. Using the average measurements between the 2 readers, areas under the curve for the pre-/post-/Δvolumes was 0.73/0.82/0.78 for T2W-magnetic resonance imaging and 0.77/0.92/0.86 for DWI, respectively. For T2W-volumetry, sensitivity and specificity using the predefined volume thresholds were 55% and 74% for pre-, 60% and 89% for post-, and 60% and 86% for Δvolume. For DWI volumetry, sensitivity and specificity were 65% and 76% for pre-, 70% and 98% for post-, and 70% and 93% for Δvolume.
Conclusions: Previously established DWI volume thresholds can be reproduced with good results. Post-CRT DWI volumetry offers the best results for the detection of patients with a complete response after CRT with an area under the curve of 0.92, sensitivity of 70%, and specificity of 98%.
Similar articles
- Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.Birlik B, Obuz F, Elibol FD, Celik AO, Sokmen S, Terzi C, Sagol O, Sarioglu S, Gorken I, Oztop I.Birlik B, et al.Magn Reson Imaging. 2015 Feb;33(2):201-12. doi: 10.1016/j.mri.2014.08.041. Epub 2014 Nov 13.Magn Reson Imaging. 2015.PMID:25460330
- Automated and Semiautomated Segmentation of Rectal Tumor Volumes on Diffusion-Weighted MRI: Can It Replace Manual Volumetry?van Heeswijk MM, Lambregts DM, van Griethuysen JJ, Oei S, Rao SX, de Graaff CA, Vliegen RF, Beets GL, Papanikolaou N, Beets-Tan RG.van Heeswijk MM, et al.Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):824-31. doi: 10.1016/j.ijrobp.2015.12.017. Epub 2015 Dec 17.Int J Radiat Oncol Biol Phys. 2016.PMID:26972655
- Best MRI predictors of complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.Sathyakumar K, Chandramohan A, Masih D, Jesudasan MR, Pulimood A, Eapen A.Sathyakumar K, et al.Br J Radiol. 2016;89(1060):20150328. doi: 10.1259/bjr.20150328. Epub 2016 Feb 1.Br J Radiol. 2016.PMID:26828967Free PMC article.
- Prospective, Multicenter Validation Study of Magnetic Resonance Volumetry for Response Assessment After Preoperative Chemoradiation in Rectal Cancer: Can the Results in the Literature be Reproduced?Martens MH, van Heeswijk MM, van den Broek JJ, Rao SX, Vandecaveye V, Vliegen RA, Schreurs WH, Beets GL, Lambregts DM, Beets-Tan RG.Martens MH, et al.Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):1005-14. doi: 10.1016/j.ijrobp.2015.09.008. Epub 2015 Sep 15.Int J Radiat Oncol Biol Phys. 2015.PMID:26581139Review.
- Utility of reassessment after neoadjuvant therapy and difficulties in interpretation.Pierredon-Foulongne MA, Nougaret S, Bibeau F, Rouanet P, Delhom E, Lonjon J, Ragu N, Colleau J, Schembri V, Guiu B, Gallix B.Pierredon-Foulongne MA, et al.Diagn Interv Imaging. 2014 May;95(5):495-503. doi: 10.1016/j.diii.2014.03.010. Epub 2014 Apr 22.Diagn Interv Imaging. 2014.PMID:24767672Review.
Cited by
- MRI VS. FDG-PET for diagnosis of response to neoadjuvant therapy in patients with locally advanced rectal cancer.Gao PF, Lu N, Liu W.Gao PF, et al.Front Oncol. 2023 Jan 18;13:1031581. doi: 10.3389/fonc.2023.1031581. eCollection 2023.Front Oncol. 2023.PMID:36741013Free PMC article.Review.
- Pelvic MRI after induction chemotherapy and before long-course chemoradiation therapy for rectal cancer: What are the imaging findings?Gollub MJ, Blazic I, Bates DDB, Campbell N, Knezevic A, Gonen M, Lynn P, Weiser MR, Garcia-Aguilar J, Hötker AM, Cercek A, Saltz L.Gollub MJ, et al.Eur Radiol. 2019 Apr;29(4):1733-1742. doi: 10.1007/s00330-018-5726-2. Epub 2018 Oct 2.Eur Radiol. 2019.PMID:30280248Free PMC article.
- Role of magnetic resonance imaging in organ-preserving strategies for the management of patients with rectal cancer.Ortega CD, Perez RO.Ortega CD, et al.Insights Imaging. 2019 May 30;10(1):59. doi: 10.1186/s13244-019-0742-6.Insights Imaging. 2019.PMID:31147789Free PMC article.Review.
- Accuracy and feasibility of estimated tumour volumetry in primary gastric gastrointestinal stromal tumours: validation using semiautomated technique in 127 patients.Tirumani SH, Shinagare AB, O'Neill AC, Nishino M, Rosenthal MH, Ramaiya NH.Tirumani SH, et al.Eur Radiol. 2016 Jan;26(1):286-95. doi: 10.1007/s00330-015-3829-6. Epub 2015 May 20.Eur Radiol. 2016.PMID:25991487Free PMC article.
- Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomics.Bulens P, Couwenberg A, Intven M, Debucquoy A, Vandecaveye V, Van Cutsem E, D'Hoore A, Wolthuis A, Mukherjee P, Gevaert O, Haustermans K.Bulens P, et al.Radiother Oncol. 2020 Jan;142:246-252. doi: 10.1016/j.radonc.2019.07.033. Epub 2019 Aug 17.Radiother Oncol. 2020.PMID:31431368Free PMC article.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Medical
Research Materials